Core A: Administrative Core

普罗米修斯联盟的首要目标是开发基于抗体的 针对三大类A类优先病毒的药物和治疗剂 引起人畜共患疾病--埃博拉病毒，内罗病毒，克里米亚-刚果出血热 病毒（CCHFV）、新大陆汉坦病毒安第斯山脉病毒（ANDV）和Sin Nombre病毒（SNV）， 和旧世界汉坦病毒Puumula病毒（PUUV）。行政核心，核心A， 作为普罗米修斯的中心，为所有项目提供管理、人员和资源 管理部门，包括行政、财务、绩效监控和报告， 合规性、项目和团队协调、内部和外部沟通、资源和 变革管理和知识产权管理。阿尔伯特·爱因斯坦医学院 （爱因斯坦）将作为普罗米修斯CETR的牵头机构， 对其业绩负责。为了实现这些目标并推进普罗米修斯的战略 研究计划，我们将制定和实施计划，以：（1）组织，监督，监测和报告 Prometheus活动;（2）促进团队互动和协调;（3）传达CETR的 对科学界和公众的使命和活动;以及（4）管理旅行，冲突， 变化、风险、知识产权、资源和试剂。

The overarching goal of the Prometheus consortium is to develop antibody-based prophylactics and therapeutics against three major groups of Category A priority viruses that cause zoonotic disease—ebolaviruses, the nairovirus Crimean-Congo hemorrhagic fever virus (CCHFV), the New-World hantaviruses Andes virus (ANDV) and Sin Nombre virus (SNV), and the Old-World hantavirus Puumula virus (PUUV). The Administrative Core, Core A, will serve as the hub for Prometheus, providing governance, personnel, and resources for all program management arms, including administrative, financial, performance monitoring and reporting, compliance, project and team coordination, internal and external communication, resource and change management, and intellectual property management. Albert Einstein College of Medicine (Einstein) will serve as the lead institution for the Prometheus CETR and bear overall responsibility for its performance. To achieve these goals and advance Prometheus’s strategic research plan, we will develop and implement plans to: (1) organize, oversee, monitor, and report Prometheus activities; (2) foster team interaction and coordination; (3) communicate the CETR’s mission and activities to the scientific community and the public; and (4) manage travel, conflict, change, risk, intellectual property, and resources and reagents.